BillionToOne, Inc.
BLLN
Rankning i aktier
#3472
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Aktiekurs
$105.11
Senast synkroniserad: 2026-10-21
Marknadsvärde
$4.96B
Förändring (1 dag)
1.56%
Förändring (1 år)
-
Land
US
Handel BillionToOne, Inc. (BLLN)
Kategori
Healthcare
Historik för aktiesplit för BillionToOne, Inc. (BLLN)
Aktien BillionToOne, Inc. (symbol: BLLN) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 22, 2026.
En BLLN-aktie köpt före Oct 22, 2026 motsvarar nu 0 BLLN-aktier.
Den senaste spliten skedde den Oct 22, 2026.
En BLLN-aktie köpt före Oct 22, 2026 motsvarar nu 0 BLLN-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
